Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01753596

Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye Disease

Status
Withdrawn
Phase
Phase 3
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Dry eye syndrome (DES) is a highly prevalent ocular condition with severe consequences for the patients reaching from ocular discomfort in its simplest form up to visual impairment and corneal ulceration in severe cases. Data from epidemiological studies indicate that DES is a common disease, especially in the elderly population, affecting up to 20% of adults aged 45 years or older. Topical lubricants are a mainstay of therapy, but data on its effect on tear film thickness and the corneal residence time are lacking. Recently, a new objective method for assessment of tear film thickness by optical coherence tomography has been developed. The present study aims to investigate the corneal residence time of an established topical lubricant compared to placebo in patients with DES and healthy controls.

Conditions

Interventions

TypeNameDescription
DEVICEGENTEAL HA® Eye Drops (NOVARTIS, Switzerland)
OTHERPhysiological Sodium Chloride solution (0,9%)Placebo

Timeline

Start date
2014-12-01
Primary completion
2014-12-01
Completion
2015-02-01
First posted
2012-12-20
Last updated
2014-11-14

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT01753596. Inclusion in this directory is not an endorsement.